Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Topiramate 25mg/5ml oral suspension
040801050AABXBX
|
Topiramate | Topiramate | Central Nervous System | 303 |
|
Hydromorphone 8mg modified-release capsules
040702050AAACAC
|
Hydromorphone hydrochloride | Hydromorphone hydrochloride | Central Nervous System | 302 |
|
Morphgesic SR 100mg tablets
0407020Q0BNADAH
|
Morphgesic | Morphine sulfate | Central Nervous System | 301 |
|
Almuriva 9.5mg/24hours transdermal patches
0411000E0BKABAG
|
Almuriva | Rivastigmine | Central Nervous System | 300 |
|
Brintellix 20mg tablets
0403040ABBBACAC
|
Brintellix | Vortioxetine | Central Nervous System | 300 |
|
Spiroco XL 4mg tablets
0409010H0BDABAL
|
Spiroco XL | Ropinirole hydrochloride | Central Nervous System | 300 |
|
Diamorphine 100mg powder for solution for injection ampoules
0407020K0AAAFAF
|
Diamorphine hydrochloride (Systemic) | Diamorphine hydrochloride (Systemic) | Central Nervous System | 297 |
|
Elvanse Adult 20mg capsules
0404000U0BDADAA
|
Elvanse Adult | Lisdexamfetamine dimesylate | Central Nervous System | 296 |
|
Fentanyl 100microgram buccal tablets sugar free
0407020A0AABCBC
|
Fentanyl | Fentanyl | Central Nervous System | 296 |
|
Panitaz 10micrograms/hour transdermal patches
0407020B0BLABAI
|
Panitaz | Buprenorphine | Central Nervous System | 296 |
|
Epival CR 300mg tablets
0408010W0BHAAA1
|
Epival (Epilepsy) | Sodium valproate | Central Nervous System | 295 |
|
Li-Liquid 509mg/5ml oral solution
0402030P0BDAAAL
|
Li-Liquid | Lithium citrate | Central Nervous System | 294 |
|
Dacepton 100mg/20ml solution for infusion vials
0409010ACBBABAB
|
Dacepton | Apomorphine hydrochloride hemihydrate | Central Nervous System | 293 |
|
Ebixa 20mg tablets
0411000G0BBACAD
|
Ebixa | Memantine hydrochloride | Central Nervous System | 292 |
|
Cabergoline 2mg tablets
0409010U0AAABAB
|
Cabergoline (Parkinsonism) | Cabergoline | Central Nervous System | 291 |
|
Hydromorphone 4mg modified-release capsules
040702050AAAGAG
|
Hydromorphone hydrochloride | Hydromorphone hydrochloride | Central Nervous System | 291 |
|
Vydura 75mg oral lyophilisates
0407041ADBBAAAA
|
Vydura | Rimegepant | Central Nervous System | 291 |
|
Ebixa 5mg/0.5ml pump actuation oral solution
0411000G0BBABAB
|
Ebixa | Memantine hydrochloride | Central Nervous System | 290 |
|
Hapoctasin 70micrograms/hour transdermal patches
0407020B0BGACAG
|
Hapoctasin | Buprenorphine | Central Nervous System | 289 |
|
Mirapexin 0.18mg tablets
0409010W0BBABAB
|
Mirapexin | Pramipexole | Central Nervous System | 288 |
|
Zyprexa 5mg Velotabs
040201060BBAEAE
|
Zyprexa | Olanzapine | Central Nervous System | 288 |
|
Renocontin 20mg modified-release tablets
0407020ADBRADAG
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 286 |
|
Haldol Decanoate 100mg/1ml solution for injection ampoules
0402020T0BBABAB
|
Haldol Decan | Haloperidol decanoate | Central Nervous System | 285 |
|
Lamotrigine 50mg/5ml oral suspension
0408010H0AAA3A3
|
Lamotrigine | Lamotrigine | Central Nervous System | 284 |
|
Sertraline 25mg/5ml oral suspension
0403030Q0AAAXAX
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 284 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.